Danske Bank’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Danske Bank’s Portfolio NURO Stock Details NURO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2	Closed	-$8	–	1497
2024 Q4	$8	Hold	2	–	–	﹤0.01%	1350
2024 Q3	$8	Buy	+2	New	+$7	﹤0.01%	1539

Other funds holding NURO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Danske Bank's NURO Position: Q1 2025 in Review

Danske Bank sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q1 2025, closing a stake of 2 shares — an estimated $8 sold.

Danske Bank first reported a position in NURO in Q3 2024 and held it in 2 quarters. The position peaked at $8 in Q4 2024. 14 funds tracked by Wall St. Rank hold NURO as of Q1 2025.

Danske Bank reported no remaining NeuroMetrix, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Danske Bank sold 2 NeuroMetrix, Inc. Common Stock shares in Q1 2025, an estimated $8.
Danske Bank first reported a position in NeuroMetrix, Inc. Common Stock in Q3 2024 and held it in 2 quarters.
Danske Bank's NeuroMetrix, Inc. Common Stock position peaked at $8 in Q4 2024.
14 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q1 2025.

Based on Danske Bank's 13F filing for Q1 2025, filed 18 Dec 2025.